Asmanex twisthaler and Haldol solutab drug interactions - a phase IV clinical study of FDA data

Summary:

We study 3,153 people who take Asmanex twisthaler or Haldol solutab. There is no drug interaction reported.

The phase IV clinical study analyzes what interactions people who take Asmanex twisthaler and Haldol solutab have. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 28, 2022

No report is found.


What is Asmanex twisthaler?

Asmanex twisthaler has active ingredients of mometasone furoate. It is often used in asthma. eHealthMe is studying from 3,121 Asmanex twisthaler users for its effectiveness, alternative drugs and more.

What is Haldol solutab?

Haldol solutab has active ingredients of haloperidol. eHealthMe is studying from 32 Haldol solutab users for its effectiveness, alternative drugs and more.

Do you take Asmanex twisthaler and Haldol solutab?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate and haloperidol (the active ingredients of Asmanex twisthaler and Haldol solutab, respectively), and Asmanex twisthaler and Haldol solutab (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Asmanex twisthaler and Haldol solutab.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: